According to a randomized clinical trial (RCT), a reduction in the serum level of ALT and AST was observed in low-calorie, low-carbohydrate, soy-containing group in NAFLD patients through 8 weeks45. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.